{
    "2018-12-14": [
        [
            {
                "time": "2018-09-10",
                "original_text": "Lilly to Acquire Pre-Clinical Pain Program from Hydra Biosciences",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Acquire",
                        "Pre-Clinical",
                        "Pain",
                        "Program",
                        "Hydra Biosciences"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Do Analysts See Any Upside for Ionis Stock?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Upside",
                        "Ionis",
                        "Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-20",
                "original_text": "Taking Stock of Ionis’s Performance",
                "features": {
                    "keywords": [
                        "Taking",
                        "Stock",
                        "Ionis",
                        "Performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-05",
                "original_text": "Understanding Ionis Pharmaceuticals’ Operational Performance",
                "features": {
                    "keywords": [
                        "Understanding",
                        "Ionis",
                        "Pharmaceuticals",
                        "Operational",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-10",
                "original_text": "Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Favorable",
                        "Ruling",
                        "Sanofi",
                        "Lantus"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-01-15",
                "original_text": "Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Outperforming",
                        "Medical",
                        "Stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "AZN",
                        "RHHBY",
                        "Cancer",
                        "Drugs",
                        "LLY",
                        "BMY",
                        "Deals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-10",
                "original_text": "5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "Stocks",
                        "Promise",
                        "Bull",
                        "Run"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-05",
                "original_text": "Merck bolsters animal health unit with $2.4 bln Antelliq purchase",
                "features": {
                    "keywords": [
                        "Merck",
                        "bolsters",
                        "animal",
                        "health",
                        "unit",
                        "Antelliq",
                        "purchase"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-15",
                "original_text": "Do Analysts See Any Upside for Biogen Stock?",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Upside",
                        "Biogen",
                        "Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Evidation",
                        "Health",
                        "Expand",
                        "Collaboration",
                        "Analyze",
                        "Data",
                        "Smartphones",
                        "Connected",
                        "Sensors"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}